Australia’s trusted independent immunisation experts


Jacoby P, Glover C, Damon C, Fathima P, Pillsbury A, Durrheim D, Gold M, Leeb A, Snelling T . Timeliness of signal detection for adverse events following influenza vaccination in young children: a simulation case study. BMJ Open 2020;10:e031851 . [Full text]

Damiano JA, Deng L, Li WH, Burgess R, Schneider AL, Crawford NW, Buttery J, Gold M, Richmond P, Macartney KK, Hildebrand MS, Scheffer IE, Wood N, Berkovic SF. SCN1A variants in vaccine-related febrile seizures: a prospective study. Annals of Neurology. 2020;87:281-288. [Abstract]

Thielemans E, Oliver J, McMinn A, Baker C, Britton PN, Clark J, Marshall H, Blyth CC, Francis J, Buttery J, Smeesters PR, Crawford N, Steer AC. Clinical description and outcomes of Australian children With invasive group A streptococcal disease. The Pediatric Infectious Diseases Journal. 20 Feb 2020. . [Abstract - Epub]

Maguire J, Beard B, Meder K, Dey A, Macartney K, McIntyre P. Australian vaccine preventable disease epidemiological review series: invasive Haemophilus influenzae type b disease, 2000–2017. Communicable Diseases Intelligence. 2020;44. [Full text]

Jayasinghe S, Sheridan S, Macartney K. Herpes zoster vaccination in Australia: what’s available and who benefits? . Australian Prescriber. 2020;43:2–6 . [Full text]

Estcourt MJ, Campbell DE, Gold MS, Richmond P, Allen KJ, Quinn HE, Marsh JA, Peters RL, Valerio C, Dai D, Waddington CS, Wood NJ, McIntyre PB, Holt PG, Snelling TL. Whole cell pertussis vaccination and decreased risk of IgE-mediated food allergy: a nested case-control study. The Journal of Allergy and Clinical Immunology: In Practice. doi: [EPub ahead of print]. [Abstract - Epub]

Frank O, Bernardo C, Gonzalez D, Macartney K, Menzies R, Stocks N. Pneumococcal vaccination uptake among patients aged 65 years or over in Australian general practice. Human Vaccines & Immunotherapeutics. 17 January 2020. [EPub ahead of print].. [Full text - Epub]

Wolfenden L, Bolsewicz K, Grady A, McCrabb S, Kingsland M, Wiggers J, Bauman A, Wyse R, Nathan N, Sutherland R, Hodder RK, Fernandez M, Lewis C, Taylor N, McKay H, Grimshaw J, Hall A, Moullin J, Albers B, Batchelor S, Attia J, Milat A, Bailey A, Rissel C,. Optimisation: defining and exploring a concept to enhance the impact of public health initiatives. Health Research Policy and Systems. 2019;17 (108). doi:10.1186/s12961-019-0502-6. [Full text]

Oliver J, Thielemans E, McMinn A, Baker C, Britton PN, Clark JE, Marshall HS, Blyth CC, Francis J, Buttery J, Steer AC, Crawford NW and on behalf of the PAEDS investigators. Invasive group A Streptococcus disease in Australian children: 2016 to 2018 – a descriptive cohort study. BMC Public Health 2019;19:1750 doi:10.1186/s12889-019-8085-2. [Full text]

Newall AT, Wood JG, Chen C, McIntyre P, Beutels P. Reply to letter: Retrospective cost-effectiveness of the 23-valent pneumococcal polysaccharide vaccination program in Australia. Vaccine. 2019;52:7534. doi: 10.1016/j.vaccine.2019.09.108. [Full text]